Table 2.
Presentation | Total, N = 122 035 | No Cocaine, n = 118 953 | Cocaine, n = 3082 | P Value |
---|---|---|---|---|
Indication for cardiac catheterization | ||||
ACS | 25.5 | 25.2 | 36.3 | <0.001 |
Chest pain | 44.4 | 44.4 | 41.4 | |
IHD | 9.1 | 9.1 | 6.4 | |
Positive functional study | 10.7 | 10.7 | 7.2 | |
Cardiomyopathy | 3.8 | 3.8 | 4.7 | |
Valvular disease | 2.8 | 2.9 | 1.2 | |
Other | 3.8 | 3.8 | 2.8 | |
Cardiogenic shock | 0.4 | 0.4 | 0.8 | <0.001 |
Procedural status | ||||
Elective | 70.3 | 70.6 | 57.1 | <0.001 |
Emergent | 3.8 | 3.7 | 7.5 | |
Urgent | 25.9 | 25.6 | 35.4 | |
Salvage | 0.1 | 0.1 | 0 | |
Preprocedural stress testing | 45 | 45.2 | 37.9 | <0.001 |
Results | ||||
Positive | 42.1 | 42.1 | 42.6 | 0.83 |
Negative | 2.8 | 2.8 | 3.3 | |
Equivocal | 1.8 | 1.8 | 1.5 | |
Dysrhythmia | 0 | 0 | 0 | |
Indeterminate | 0.4 | 0.4 | 0.4 | |
Unknown | 52.9 | 53 | 52.1 | |
Medications at presentation | ||||
β‐Blockers | 60 | 60.3 | 50.4 | <0.001 |
Nitrates | 38 | 38.1 | 33.1 | <0.001 |
CCBs | 23.8 | 23.8 | 24.1 | 0.62 |
Statins | 62.9 | 63.2 | 50.6 | <0.001 |
Angiographic findings | ||||
1‐vessel obstructive | 35.6 | 35.3 | 45.8 | <0.001 |
2‐vessel obstructive | 26.3 | 26.3 | 26 | |
3‐vessel/LM obstructive | 38.1 | 38.3 | 28.2 |
Abbreviations: ACS, acute coronary syndrome; CAD, coronary artery disease; CCB, calcium channel blocker; IHD, ischemic heart disease; LM, left main artery.
Data are presented as percentages (%).